Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsRFA-HL-26-017

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trial

National Institutes of Health opportunity RFA-HL-26-017

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthRFA-HL-26-017Grants.gov
Related Grants
Health● Open
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Varies
07 Jan 2027(97d)
Health● Open
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
Varies
05 Mar 2029(885d)
Health● Open
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Varies
05 Apr 2027(185d)
HealthUpcoming
Interdisciplinary Research Networks to Advance Biomedical Research on Resilience and Health Optimization
Varies
Funding Amount
Varies
USD
Application Deadline
23 December 2027
447 days remaining
Opens: 22 Nov 2024
Apply Now
Programme Details
Programme Code
RFA-HL-26-017